Prot #AC-203-EBS-007: An International, Multicenter, Randomized, Double-Blind, Parallel Group, VehicleControlled, Phase 2/3 Study with Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epider

Project: Research project

Project Details

StatusActive
Effective start/end date6/26/24 → 6/26/27

Funding

  • Cato Research Ltd. (Prot #AC-203-EBS-007 // Prot #AC-203-EBS-007)
  • TWi Biotechnology, Inc. (Prot #AC-203-EBS-007 // Prot #AC-203-EBS-007)